1,721,300 research outputs found
The use of 18FDG PET in NSCLC
Postmus, P.E. [Promotor]Teule, G.J.J. [Promotor]Hoekstra, O.S. [Copromotor]Smit, E.F. [Copromotor
Combined Modality Treatment for Locally-Advanced Non-Small-Cell Lung Cancer: The ongoing search for optimal management
Smit, E.F. [Promotor]Senan, S. [Promotor
Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Smit, E.F. [Promotor]Heideman, D.A.M. [Copromotor
In vivo quantification of proliferation and glucose metabolism in lung cancer patients
Boellaard, R. [Promotor]Smit, E.F. [Promotor
New treatment strategies in patients with advanced non-small cell lung cancer with a KRAS mutation
Smit, E.F. [Promotor]Dingemans, A.M.C. [Copromotor
Management of advanced non-small cell lung cancer: moving towards a more personalised approach
Smit, E.F. [Promotor]Senan, S. [Copromotor
Response evaluation during targeted therapy: early incorporation of imaging biomarkers
Smit, E.F. [Promotor]Hoekstra, O.S. [Promotor]Lubberink, M. [Copromotor
Molecular profiling for risk assessment of pre-invasive endobronchial lesions
Snijders, P.J.F. [Promotor]Smit, E.F. [Promotor]Heideman, D.A.M. [Copromotor
Therapeutic targets and biomarkers in lung cancer
Smit, E.F. [Promotor]Giaccone, G. [Promotor]Rodriquez, J.A. [Copromotor]Ylstra, B. [Copromotor
Studies on chemoprevention, early detection and prognosis of lung cancer
Smit, E.F. [Promotor]Snijders, P.J.F. [Promotor]Sutedja, T.G. [Copromotor]Heideman, D.A.M. [Copromotor
- …
